International consensus on use of continuous glucose monitoring

T Danne, R Nimri, T Battelino, RM Bergenstal… - Diabetes …, 2017 - Am Diabetes Assoc
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for
assessing glycemic control. However, it does not reflect intra-and interday glycemic …

Recent advances in intelligent wearable medical devices integrating biosensing and drug delivery

M Tan, Y Xu, Z Gao, T Yuan, Q Liu, R Yang… - Advanced …, 2022 - Wiley Online Library
The primary roles of precision medicine are to perform real‐time examination, administer on‐
demand medication, and apply instruments continuously. However, most current therapeutic …

Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes

D Rodbard - Diabetes technology & therapeutics, 2017 - liebertpub.com
Abstract Supplementary Table S1 Continuous Glucose Monitoring (CGM) has been
demonstrated to be clinically valuable, reducing risks of hypoglycemia and hyperglycemia …

The UVA/Padova type 1 diabetes simulator goes from single meal to single day

R Visentin, E Campos-Náñez… - Journal of diabetes …, 2018 - journals.sagepub.com
Background: A new version of the UVA/Padova Type 1 Diabetes (T1D) Simulator is
presented which provides a more realistic testing scenario. The upgrades to the previous …

Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to …

JG Chase, JC Preiser, JL Dickson, A Pironet… - Biomedical engineering …, 2018 - Springer
Critical care, like many healthcare areas, is under a dual assault from significantly
increasing demographic and economic pressures. Intensive care unit (ICU) patients are …

Individualized model predictive control for the artificial pancreas: In silico evaluation of closed-loop glucose control

M Messori, GP Incremona, C Cobelli… - IEEE Control Systems …, 2018 - ieeexplore.ieee.org
Despite the continuous efforts devoted to AP development in the last decades, an artificial
pancreas (AP) system is not yet available on the market. One of the major issues involves …

Feasibility of long-term closed-loop control: a multicenter 6-month trial of 24/7 automated insulin delivery

B Kovatchev, P Cheng, SM Anderson… - Diabetes technology …, 2017 - liebertpub.com
Background: In the past few years, the artificial pancreas—the commonly accepted term for
closed-loop control (CLC) of blood glucose in diabetes—has become a hot topic in research …

Automated insulin delivery systems: from early research to routine care of type 1 diabetes

E Renard - Acta Diabetologica, 2023 - Springer
Automated insulin delivery (AID) systems, so-called closed-loop systems or artificial
pancreas, are based upon the concept of insulin supply driven by blood glucose levels and …

A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy

Y Zhang, M Wu, D Tan, Q Liu, R Xia, M Chen… - Journal of materials …, 2021 - pubs.rsc.org
Diabetes and its complications have become crucial public health challenges worldwide. In
this study, we aim to develop a dissolving and glucose-responsive insulin-releasing …

Human digital twin for personalized elderly type 2 diabetes management

P Thamotharan, S Srinivasan, J Kesavadev… - Journal of Clinical …, 2023 - mdpi.com
Managing Elderly type 2 diabetes (E-T2D) is challenging due to geriatric conditions (eg, co-
morbidity, multiple drug intake, etc.), and personalization becomes paramount for precision …